Cohn-Hokke P E, Wong T H, Rizzu P, Breedveld G, van der Flier W M, Scheltens P, Baas F, Heutink P, Meijers-Heijboer E J, van Swieten J C, Pijnenburg Y A L
Department of Clinical Genetics, VU University Medical Centre, De Boelelaan 1118, 1081 HZ, Amsterdam, The Netherlands,
J Neurol. 2014 Nov;261(11):2085-92. doi: 10.1007/s00415-014-7456-y. Epub 2014 Aug 10.
Genetic factors are important in all forms of dementia, especially in early onset dementia. The frequency of major gene defects in dementia has not been investigated in the Netherlands. Furthermore, whether the recently in a FTD family identified PRKAR1B gene is associated with an Alzheimer's disease (AD) like phenotype, has not been studied. With this study, we aimed to investigate the mutation frequency of the major AD and FTD genes and the PRKAR1B gene in a well-defined Dutch cohort of patients with early onset dementia. Mutation analysis of the genes PSEN1, APP, MAPT, GRN, C9orf72 and PRKAR1B was performed on DNA of 229 patients with the clinical diagnosis AD and 74 patients with the clinical diagnosis FTD below the age of 70 years. PSEN1 and APP mutations were found in, respectively 3.5 and 0.4 % of AD patients, and none in FTD patients. C9orf72 repeat expansions were present in 0.4 % of AD and in 9.9 % of FTD patients, whereas MAPT and GRN mutations both were present in 0.4 % in AD patients, and in 1.4 % resp. 2.7 % in FTD patients. We did not find any pathogenic mutations in the PRKAR1B gene. PSEN1 mutations are the most common genetic cause in Dutch AD patients, whereas MAPT and GRN mutations were found in less than 5 percent. C9orf72 repeat expansions were the most common genetic defect in FTD patients. No pathogenic PRKAR1B mutations were found in the early onset AD and FTD patients of our study.
遗传因素在所有形式的痴呆中都很重要,尤其是在早发性痴呆中。荷兰尚未对痴呆中主要基因缺陷的频率进行调查。此外,最近在一个额颞叶痴呆(FTD)家族中发现的PRKAR1B基因是否与阿尔茨海默病(AD)样表型相关,也尚未得到研究。通过本研究,我们旨在调查荷兰一个明确界定的早发性痴呆患者队列中主要AD和FTD基因以及PRKAR1B基因的突变频率。对229例临床诊断为AD且年龄在70岁以下的患者以及74例临床诊断为FTD的患者的DNA进行了PSEN1、APP、MAPT、GRN、C9orf72和PRKAR1B基因的突变分析。在AD患者中,分别有3.5%和0.4%发现了PSEN1和APP突变,而FTD患者中未发现。C9orf72重复扩增在0.4%的AD患者和9.9%的FTD患者中存在,而MAPT和GRN突变在AD患者中均为0.4%,在FTD患者中分别为1.4%和2.7%。我们在PRKAR1B基因中未发现任何致病突变。PSEN1突变是荷兰AD患者最常见的遗传原因,而MAPT和GRN突变的发现率不到5%。C9orf72重复扩增是FTD患者中最常见的遗传缺陷。在我们研究的早发性AD和FTD患者中未发现致病的PRKAR1B突变。